A cancer expert from Oxford is leading one of several major new trials exploring how myeloma develops and how it could be prevented.
Objective: To develop a hospital-wide protocol for emergent evaluation of patients with stroke-like symptoms who are receiving anti-amyloid monoclonal antibodies (Aβ immunotherapy). Background: Aβ ...
Method: We conducted a targeted synthesis of seven pivotal trials, NAVIGATE ESUS, RESPECT ESUS, CRYSTAL AF, ARCADIA, COMPASS, ESCAPE NA, and AF ESUS, to explore diagnostic markers and therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results